.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Royal Leaf is stocked at 30 licensed dispensaries across New York and Washington, 29 of them in New York, with the deepest coverage in New York, Rochester, Farmingdale, Buffalo, and Cohoes. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Royal Leaf’s category mix in July 2026 concentrated heavily in Concentrates at 62.76% share with a month-over-month surge of 197.10%, while Vapor Pens climbed to 13.76% share on an 798.04% MoM spike; in contrast, Flower slid to 21.06% share with a -12.91% MoM change and a -25.22% year-over-year decline. Pre-Roll remained a small 2.42% share despite 122.88% YoY growth and a -14.62% MoM contraction, and the brand’s average price rose 90.50% YoY to $66.14, indicating a sharp premiumization relative to prior periods. Taken together, this mix shift implies Royal Leaf is reallocating demand from Flower into higher-priced extract formats, using rapid MoM velocity in Concentrates and Pens to offset Flower’s YoY softness.
Positioning-wise, Concentrates rank 14 in New York and carry a high average price of $96.23 alongside a 197.10% MoM acceleration, while Vapor Pens’ 798.04% MoM growth at a $62.22 average price suggests quick traction in a neighboring premium-adjacent format; Flower’s -25.22% YoY and -12.91% MoM declines tighten its role as a secondary volume driver. With Concentrates at 62.76% share and Pre-Roll limited to 2.42% despite 122.88% YoY growth, the brand’s stance skews toward extract-led premium baskets, implying near-term gains will hinge on sustaining rank momentum in New York Concentrates while using Pens’ surge to diversify price points without diluting the premium tilt.
Competitive Landscape
Royal Leaf sits at rank #14 in NY Concentrates in July 2026, up 2 places from #16 in April 2026, and matching its peak rank of #14 in July 2026; with no year-over-year rank published, the 3-month climb of 12.5% in rank position (from #16 to #14) contrasts with UMAMII jumping from #27 to #3 year over year and Jetpacks edging from #3 to #2 while posting 56.8% sales growth, indicating Royal Leaf’s incremental rank gains are outpaced by faster-moving leaders and implying a need to convert short-term momentum into sustained share capture before the gap hardens.
Notable Products
Guavaberry Live Rosin (2g) posted the headline move in July 2026 with a +435.9% month-over-month surge to the number 1 rank, while Royal Leaf Haze (7g) slid -16.2% to rank 10, marking the steepest decline among the top ten. Shake Shack Cold Cured Live Rosin (2g) also accelerated by +274.2% to rank 3, and Black Maple Pre-Roll 2-Pack (1g) advanced +64.8% to rank 8, indicating momentum skewed toward concentrates and a selective pre-roll. With three concentrates in the top seven and Flower clustered at ranks 6, 9, and 10, the product mix is tilting toward higher-potency formats, implying Royal Leaf is consolidating share in rosin-led offerings while Flower positions as a secondary volume lane.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
